{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T12:38:55Z","timestamp":1773059935126,"version":"3.50.1"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2021,6,22]],"date-time":"2021-06-22T00:00:00Z","timestamp":1624320000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,6,22]],"date-time":"2021-06-22T00:00:00Z","timestamp":1624320000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1007\/s10620-021-07016-z","type":"journal-article","created":{"date-parts":[[2021,6,22]],"date-time":"2021-06-22T16:02:50Z","timestamp":1624377770000},"page":"2462-2470","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Role of Cross-Sectional Imaging in Pediatric Inflammatory Bowel Disease"],"prefix":"10.1007","volume":"67","author":[{"given":"Aur\u00e9lie","family":"Grandmougin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ferdinando","family":"D\u2019Amico","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Remen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvio","family":"Danese","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marjorie","family":"Bonneton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie Agnes","family":"Galloy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laurent","family":"Peyrin-Biroulet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Val\u00e9rie","family":"Laurent","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,6,22]]},"reference":[{"key":"7016_CR1","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1016\/S0140-6736(16)31711-1","volume":"389","author":"J Torres","year":"2017","unstructured":"Torres J, Mehandru S, Colombel J-F et al. Crohn\u2019s disease. Lancet 2017;389:1741\u20131755.","journal-title":"Lancet"},{"key":"7016_CR2","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1007\/s00247-013-2712-3","volume":"43","author":"JM Ream","year":"2013","unstructured":"Ream JM, Dillman JR, Adler J et al. MRI diffusion-weighted imaging (DWI) in pediatric small bowel Crohn disease: correlation with MRI findings of active bowel wall inflammation. Pediatr Radiol 2013;43:1077\u20131085.","journal-title":"Pediatr Radiol"},{"key":"7016_CR3","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1002\/ibd.20927","volume":"15","author":"F Schnitzler","year":"2009","unstructured":"Schnitzler F, Fidder H, Ferrante M et al. Mucosal healing predicts long-term outcome of maintenance therapy with infliximab in Crohn\u2019s disease. Inflamm Bowel Dis 2009;15:1295\u20131301.","journal-title":"Inflamm Bowel Dis"},{"key":"7016_CR4","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1007\/s00247-018-4107-y","volume":"48","author":"A Mojtahed","year":"2018","unstructured":"Mojtahed A, Gee MS. Magnetic resonance enterography evaluation of Crohn disease activity and mucosal healing in young patients. Pediatr Radiol 2018;48:1273\u20131279.","journal-title":"Pediatr Radiol"},{"key":"7016_CR5","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.1097\/MIB.0000000000000103","volume":"20","author":"EI Benchimol","year":"2014","unstructured":"Benchimol EI, Manuel DG, Guttmann A et al. Changing age demographics of inflammatory bowel disease in Ontario, Canada: a population-based cohort study of epidemiology trends. Inflamm Bowel Dis 2014;20:1761\u20131769.","journal-title":"Inflamm Bowel Dis"},{"key":"7016_CR6","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1586\/17474124.2015.1083420","volume":"9","author":"D Schreiber-Dietrich","year":"2015","unstructured":"Schreiber-Dietrich D, Chiorean L, Cui X-W et al. Particularities of Crohn\u2019s disease in pediatric patients: current status and perspectives regarding imaging modalities. Expert Rev Gastroenterol Hepatol 2015;9:1313\u20131325.","journal-title":"Expert Rev Gastroenterol Hepatol"},{"issue":"255\u2013281","key":"7016_CR7","first-page":"vii","volume":"28","author":"PG Andres","year":"1999","unstructured":"Andres PG, Friedman LS. Epidemiology and the natural course of inflammatory bowel disease. Gastroenterol Clin North Am 1999;28:vii.","journal-title":"Gastroenterol Clin North Am"},{"key":"7016_CR8","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1111\/apt.15114","volume":"49","author":"M Chaparro","year":"2019","unstructured":"Chaparro M, Garre A, Ricart E et al. Differences between childhood- and adulthood-onset inflammatory bowel disease: the CAROUSEL study from GETECCU. Aliment Pharmacol Ther 2019;49:419\u2013428.","journal-title":"Aliment Pharmacol Ther"},{"key":"7016_CR9","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1093\/ecco-jcc\/jjx132","volume":"12","author":"C Nordenvall","year":"2018","unstructured":"Nordenvall C, Rosvall O, Bottai M et al. Surgical treatment in childhood-onset inflammatory bowel disease-a nationwide register-based study of 4695 incident patients in Sweden 2002\u20132014. J Crohns Colitis 2018;12:157\u2013166.","journal-title":"J Crohns Colitis"},{"key":"7016_CR10","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1097\/MEG.0000000000001072","volume":"30","author":"D Herzog","year":"2018","unstructured":"Herzog D, Fournier N, Buehr P et al. Age at disease onset of inflammatory bowel disease is associated with later extraintestinal manifestations and complications. Eur J Gastroenterol Hepatol 2018;30:598\u2013607.","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"7016_CR11","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1002\/ibd.21493","volume":"17","author":"A Levine","year":"2011","unstructured":"Levine A, Griffiths A, Markowitz J et al. Pediatric modification of the Montreal classification for inflammatory bowel disease: the Paris classification. Inflamm Bowel Dis 2011;17:1314\u20131321.","journal-title":"Inflamm Bowel Dis"},{"key":"7016_CR12","doi-asserted-by":"publisher","first-page":"31","DOI":"10.3748\/wjg.v20.i1.31","volume":"20","author":"HJ Freeman","year":"2014","unstructured":"Freeman HJ. Natural history and long-term clinical course of Crohn\u2019s disease. World J Gastroenterol 2014;20:31\u201336.","journal-title":"World J Gastroenterol"},{"key":"7016_CR13","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.dld.2017.10.006","volume":"50","author":"B Sahn","year":"2018","unstructured":"Sahn B, De Matos V, Stein R et al. Histological features of ileitis differentiating pediatric Crohn disease from ulcerative colitis with backwash ileitis. Dig Liver Dis 2018;50:147\u2013153.","journal-title":"Dig Liver Dis"},{"key":"7016_CR14","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s40272-017-0266-9","volume":"20","author":"MA Cozijnsen","year":"2018","unstructured":"Cozijnsen MA, Samsom JN, de Ridder L. Anti-tumour necrosis factor therapy for paediatric Crohn\u2019s disease: improved benefits through treatment optimisation, deeper understanding of its risks, and reduced costs due to biosimilar availability. Paediatr Drugs 2018;20:19\u201328.","journal-title":"Paediatr Drugs"},{"key":"7016_CR15","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1053\/j.gastro.2008.06.081","volume":"135","author":"J Van Limbergen","year":"2008","unstructured":"Van Limbergen J, Russell RK, Drummond HE et al. Definition of phenotypic characteristics of childhood-onset inflammatory bowel disease. Gastroenterology 2008;135:1114\u20131122.","journal-title":"Gastroenterology"},{"key":"7016_CR16","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1007\/s00247-010-1627-5","volume":"40","author":"G Gorincour","year":"2010","unstructured":"Gorincour G, Aschero A, Desvignes C et al. Chronic inflammatory diseases of the bowel: diagnosis and follow-up. Pediatr Radiol 2010;40:920\u2013926.","journal-title":"Pediatr Radiol"},{"key":"7016_CR17","doi-asserted-by":"publisher","first-page":"2769","DOI":"10.1016\/S0140-6736(17)32448-0","volume":"390","author":"SC Ng","year":"2018","unstructured":"Ng SC, Shi HY, Hamidi N et al. Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies. Lancet 2018;390:2769\u20132778.","journal-title":"Lancet"},{"key":"7016_CR18","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1016\/j.gtc.2018.07.013","volume":"47","author":"MD Egberg","year":"2018","unstructured":"Egberg MD, Kappelman MD, Gulati AS. Improving care in pediatric inflammatory bowel disease. Gastroenterol Clin North Am 2018;47:909\u2013919.","journal-title":"Gastroenterol Clin North Am"},{"key":"7016_CR19","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1002\/ibd.21349","volume":"17","author":"EI Benchimol","year":"2011","unstructured":"Benchimol EI, Fortinsky KJ, Gozdyra P et al. Epidemiology of pediatric inflammatory bowel disease: a systematic review of international trends. Inflamm Bowel Dis 2011;17:423\u2013439.","journal-title":"Inflamm Bowel Dis"},{"key":"7016_CR20","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1038\/ajg.2016.177","volume":"111","author":"P Deepak","year":"2016","unstructured":"Deepak P, Fletcher JG, Fidler JL et al. Radiological response is associated with better long-term outcomes and is a potential treatment target in patients with small bowel Crohn\u2019s disease. Am J Gastroenterol 2016;111:997\u20131006.","journal-title":"Am J Gastroenterol"},{"key":"7016_CR21","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1016\/j.dld.2017.03.028","volume":"49","author":"B Dirrenberger","year":"2017","unstructured":"Dirrenberger B, Clerc-Urm\u00e8s I, Germain A et al. Value of cross-sectional imaging in assessing active Crohn\u2019s disease before stoma reversal. Dig Liver Dis 2017;49:864\u2013871.","journal-title":"Dig Liver Dis"},{"key":"7016_CR22","doi-asserted-by":"publisher","first-page":"E25","DOI":"10.1097\/MIB.0000000000000293","volume":"21","author":"L Peyrin-Biroulet","year":"2015","unstructured":"Peyrin-Biroulet L, Laurent V. Is diffusion-weighted magnetic resonance imaging for assessing crohn\u2019s disease ready for prime time? Experience with the Nancy score. Inflamm Bowel Dis 2015;21:E25.","journal-title":"Inflamm Bowel Dis"},{"key":"7016_CR23","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1136\/gut.2009.197665","volume":"59","author":"A Oussalah","year":"2010","unstructured":"Oussalah A, Laurent V, Bruot O et al. Diffusion-weighted magnetic resonance without bowel preparation for detecting colonic inflammation in inflammatory bowel disease. Gut 2010;59:1056\u20131065.","journal-title":"Gut"},{"key":"7016_CR24","doi-asserted-by":"publisher","first-page":"896","DOI":"10.2214\/AJR.16.16079","volume":"207","author":"MP Moy","year":"2016","unstructured":"Moy MP, Kaplan JL, Moran CJ et al. MR enterographic findings as biomarkers of mucosal healing in young patients with Crohn disease. AJR Am J Roentgenol 2016;207:896\u2013902.","journal-title":"AJR Am J Roentgenol"},{"key":"7016_CR25","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1053\/j.gastro.2013.07.041","volume":"145","author":"AD Frolkis","year":"2013","unstructured":"Frolkis AD, Dykeman J, Negr\u00f3n ME et al. Risk of surgery for inflammatory bowel diseases has decreased over time: a systematic review and meta-analysis of population-based studies. Gastroenterology 2013;145:996\u20131006.","journal-title":"Gastroenterology"},{"key":"7016_CR26","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1002\/ibd.21506","volume":"17","author":"B Pariente","year":"2011","unstructured":"Pariente B, Cosnes J, Danese S et al. Development of the Crohn\u2019s disease digestive damage score, the L\u00e9mann score. Inflamm Bowel Dis 2011;17:1415\u20131422.","journal-title":"Inflamm Bowel Dis"},{"issue":"1309\u20131323","key":"7016_CR27","first-page":"e4","volume":"18","author":"M Allocca","year":"2020","unstructured":"Allocca M, Danese S, Laurent V et al. Use of cross-sectional imaging for tight monitoring of inflammatory bowel diseases. Clin Gastroenterol Hepatol 2020;18:e4.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"7016_CR28","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1097\/MEG.0000000000001090","volume":"30","author":"H Ojidu","year":"2018","unstructured":"Ojidu H, Palmer H, Lewandowski J et al. Patient tolerance and acceptance of different colonic imaging modalities: an observational cohort study. Eur J Gastroenterol Hepatol 2018;30:520\u2013525.","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"7016_CR29","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/S2468-1253(18)30054-2","volume":"3","author":"L Pouillon","year":"2018","unstructured":"Pouillon L, Laurent V, Pouillon M et al. Diffusion-weighted MRI in inflammatory bowel disease. Lancet Gastroenterol Hepatol 2018;3:433\u2013443.","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"7016_CR30","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1097\/MIB.0000000000001143","volume":"23","author":"SR Fernandes","year":"2017","unstructured":"Fernandes SR, Rodrigues RV, Bernardo S et al. Transmural healing is associated with improved long-term outcomes of patients with crohn\u2019s disease. Inflamm Bowel Dis 2017;23:1403\u20131409.","journal-title":"Inflamm Bowel Dis"},{"key":"7016_CR31","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1001\/jamapediatrics.2017.3400","volume":"171","author":"HM Yoon","year":"2017","unstructured":"Yoon HM, Suh CH, Kim JR et al. Diagnostic performance of magnetic resonance enterography for detection of active inflammation in children and adolescents with inflammatory bowel disease: a systematic review and diagnostic meta-analysis. JAMA Pediatr 2017;171:1208\u20131216.","journal-title":"JAMA Pediatr"},{"key":"7016_CR32","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1007\/s00247-017-3790-4","volume":"47","author":"PC Church","year":"2017","unstructured":"Church PC, Greer MLC, Cytter-Kuint R et al. Magnetic resonance enterography has good inter-rater agreement and diagnostic accuracy for detecting inflammation in pediatric Crohn disease. Pediatr Radiol 2017;47:565\u2013575.","journal-title":"Pediatr Radiol"},{"key":"7016_CR33","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1097\/MPG.0000000000000976","volume":"62","author":"CG Sauer","year":"2016","unstructured":"Sauer CG, Middleton JP, McCracken C et al. Magnetic resonance enterography healing and magnetic resonance enterography remission predicts improved outcome in pediatric crohn disease. J Pediatr Gastroenterol Nutr 2016;62:378\u2013383.","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"7016_CR34","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1093\/ecco-jcc\/jjy098","volume":"12","author":"M-L Thierry","year":"2018","unstructured":"Thierry M-L, Rousseau H, Pouillon L et al. Accuracy of diffusion-weighted magnetic resonance imaging in detecting mucosal healing and treatment response, and in predicting surgery, in crohn\u2019s disease. J Crohns Colitis 2018;12:1180\u20131190.","journal-title":"J Crohns Colitis"},{"key":"7016_CR35","volume-title":"Statistical power analysis for the behavioral sciences","author":"J Cohen","year":"1988","unstructured":"Cohen J. Statistical power analysis for the behavioral sciences, 2nd edn. Hillsdale: L. Erlbaum Associates; 1988.","edition":"2"},{"key":"7016_CR36","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1053\/j.gastro.2019.03.022","volume":"157","author":"DR Mack","year":"2019","unstructured":"Mack DR, Benchimol EI, Critch J et al. Canadian association of gastroenterology clinical practice guideline for the medical management of pediatric luminal Crohn\u2019s disease. Gastroenterology 2019;157:320\u2013348.","journal-title":"Gastroenterology"},{"key":"7016_CR37","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1097\/MCG.0b013e3182732ff5","volume":"47","author":"MT Osterman","year":"2013","unstructured":"Osterman MT. Mucosal healing in inflammatory bowel disease. J Clin Gastroenterol 2013;47:212\u2013221.","journal-title":"J Clin Gastroenterol"},{"key":"7016_CR38","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1053\/j.gastro.2009.09.056","volume":"138","author":"F Baert","year":"2010","unstructured":"Baert F, Moortgat L, Van Assche G et al. Mucosal healing predicts sustained clinical remission in patients with early-stage Crohn\u2019s disease. Gastroenterology 2010;138:463\u2013468.","journal-title":"Gastroenterology"},{"key":"7016_CR39","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1097\/MIB.0000000000001176","volume":"23","author":"SL Santha","year":"2017","unstructured":"Santha SL, Shankar PR, Pan A et al. Mucosal healing in clinical practice: a single-center pediatric IBD experience. Inflamm Bowel Dis 2017;23:1447\u20131453.","journal-title":"Inflamm Bowel Dis"},{"key":"7016_CR40","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1038\/ajg.2015.233","volume":"110","author":"L Peyrin-Biroulet","year":"2015","unstructured":"Peyrin-Biroulet L, Sandborn W, Sands BE et al. Selecting therapeutic targets in inflammatory bowel disease (STRIDE): determining therapeutic goals for treat-to-target. Am J Gastroenterol 2015;110:1324\u20131338.","journal-title":"Am J Gastroenterol"},{"key":"7016_CR41","unstructured":"Kaushal P, Somwaru AS, Charabaty A, et al. MR enterography of inflammatory bowel disease with endoscopic correlation. Radiographics\u202f: a review publication of the Radiological Society of North America, Inc 2017. https:\/\/pubmed.ncbi.nlm.nih.gov\/27885894\/?from_term=small+ulcerations++AND+MRI+accuracy&from_pos=8. Accessed 19 May 2020."},{"key":"7016_CR42","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1053\/j.gastro.2020.12.031","volume":"160","author":"D Turner","year":"2020","unstructured":"Turner D, Ricciuto A, Lewis A et al. STRIDE-II: an update on the selecting therapeutic targets in inflammatory bowel disease (STRIDE) initiative of the international organization for the study of IBD (IOIBD): determining therapeutic goals for treat-to-target strategies in IBD. Gastroenterology 2020;160:1570\u20131583.","journal-title":"Gastroenterology"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-021-07016-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10620-021-07016-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-021-07016-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,4]],"date-time":"2022-06-04T17:15:19Z","timestamp":1654362919000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10620-021-07016-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,22]]},"references-count":42,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["7016"],"URL":"https:\/\/doi.org\/10.1007\/s10620-021-07016-z","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,22]]},"assertion":[{"value":"4 February 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 June 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"A Grandmougin declares no conflict of interest. F D\u2019Amico declares no conflict of interest. T Remen declares no conflict of interest. M Bonneton declares no conflict of interest. MA Galloy declares no conflict of interest. S Danese has served as a speaker, consultant, and advisory board member for Schering-Plough, AbbVie, Actelion, Alphawasserman, AstraZeneca, Cellerix, Cosmo Pharmaceuticals, Ferring, Genentech, Grunenthal, Johnson and Johnson, Millenium Takeda, MSD, Nikkiso Europe GmbH, Novo Nordisk, Nycomed, Pfizer, Pharmacosmos, UCB Pharma and Vifor. L Peyrin-Biroulet has served as a speaker, consultant and advisory board member for Merck, Abbvie, Janssen, Genentech, Mitsubishi, Ferring, Norgine, Tillots, Vifor, Hospira\/Pfizer, Celltrion, Takeda, Biogaran, Boerhinger-Ingelheim, Lilly, HAC-Pharma, Index Pharmaceuticals, Amgen, Sandoz, Forward Pharma GmbH, Celgene, Biogen, Lycera, Samsung Bioepis, Theravance. V Laurent declares no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}